Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,240
Closed -$1.39M 1667
2025
Q4
$1.39M Buy
12,240
+9,990
+444% +$1.21M 0.03% 809
2025
Q3
$299K Sell
2,250
-6,475
-74% -$889K 0.01% 1378
2025
Q2
$1.24M Buy
+8,725
New +$1.24M 0.03% 839
2025
Q1
Sell
-6,595
Closed -$986K 1296
2024
Q4
$986K Sell
6,595
-879
-12% -$138K 0.07% 432
2024
Q3
$1.23M Buy
+7,474
New +$1.1M 0.08% 363
2024
Q1
Sell
-2,565
Closed -$269K 1455
2023
Q4
$269K Sell
2,565
-2,853
-53% -$264K 0.03% 866
2023
Q3
$512K Buy
5,418
+845
+18% +$86.2K 0.05% 553
2023
Q2
$459K Sell
4,573
-1,873
-29% -$174K 0.05% 586
2023
Q1
$523K Buy
+6,446
New +$516K 0.06% 507
2022
Q3
Sell
-18,303
Closed -$1.46M 1044
2022
Q2
$1.46M Buy
18,303
+12,161
+198% +$1.23M 0.19% 143
2022
Q1
$695K Buy
+6,142
New +$690K 0.16% 185

Other funds holding DVA

Y-Intercept (HK)'s DVA Position: Q1 2026 in Review

Y-Intercept (HK) sold out of DaVita (DVA) in Q1 2026, closing a stake of 12,240 shares — an estimated $1.39M sold.

Y-Intercept (HK) first reported a position in DVA in Q1 2022 and held it in 11 quarters. The position peaked at $1.46M in Q2 2022. 583 funds tracked by Wall St. Rank hold DVA as of Q1 2026.

  • Y-Intercept (HK) reported no remaining DaVita position as of Q1 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 12,240 DaVita shares in Q1 2026, an estimated $1.39M.
  • Y-Intercept (HK) first reported a position in DaVita in Q1 2022 and held it in 11 quarters.
  • Y-Intercept (HK)'s DaVita position peaked at $1.46M in Q2 2022.
  • 583 funds tracked by Wall St. Rank held DaVita as of Q1 2026.

Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.